CLDI.WS
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
CLDI.WS
Delisted
CLDI.WS was delisted on the 17th of October, 2024.
24 hedge funds and large institutions have $3.48M invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
24
Holding in Top 10
–
Calls
$4.99M
Puts
–
Top Sellers
| 1 | -$223K | |
| 2 | -$25K | |
| 3 | -$10.5K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$8K |
| 5 |
EFI
EHP Funds Inc
Toronto,
Canada
|
-$4.93K |